We are live on ! Find out more
KURA icon

Kura Oncology
KURA

116 hedge funds and large institutions have $529M invested in Kura Oncology in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 27

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

8% more funds holding

Funds holding: 107 → 116 (+9)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2% less capital invested

Capital invested by funds: $541M → $529M (-$11.5M)

8.96% less ownership

Funds ownership: 88.57% → 79.61% (-9%)

30% less call options, than puts

Call options by funds: $263K | Put options by funds: $375K

Holders
116
Holders Change
+9
Holders Change %
+8.41%
% of All Funds
2.65%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
19
Increased
54
Reduced
27
Closed
10
Calls
$263K
Puts
$375K
Net Calls
-$112K
Net Calls Change
+$2.04M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$13.5M
2
CTA
Carillon Tower Advisers
Florida
+$11M
3
BlackRock
BlackRock
New York
+$7.55M
4
KCM
Kennedy Capital Management
Missouri
+$5.53M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.7M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.7M
2
GPP
Great Point Partners
Connecticut
-$9.74M
3
SFM
Sphera Funds Management
Israel
-$6.41M
4
Invesco
Invesco
Georgia
-$3.17M
5
SCM
Sio Capital Management
New York
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
26
Ghost Tree Capital
New York
$4.03M – – –
ACM
27
Alethea Capital Management
Washington
$3.77M – – –
Charles Schwab
28
Charles Schwab
California
$2.88M +$2.06M +107,589 +188%
Deutsche Bank
29
Deutsche Bank
Germany
$2.48M +$1.03M +53,676 +61%
TAM
30
Tiverton Asset Management
Delaware
$2.22M +$129K +6,716 +6%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.97M +$189K +9,884 +10%
CIA
32
Capital Impact Advisors
Massachusetts
$1.68M – – –
Walleye Trading
33
Walleye Trading
New York
$1.67M -$544K -28,389 -23%
Hudson Bay Capital Management
34
Hudson Bay Capital Management
Connecticut
$1.66M +$481K +25,103 +36%
Allianz Asset Management
35
Allianz Asset Management
Germany
$1.66M +$1.82M +94,909 New
Bank of America
36
Bank of America
North Carolina
$1.64M +$1.46M +76,186 +430%
MA
37
Minerva Advisors
Pennsylvania
$1.55M -$276K -14,400 -14%
CCP
38
Clough Capital Partners
Massachusetts
$1.41M -$884K -46,100 -36%
AGA
39
Altrinsic Global Advisors
Connecticut
$1.4M – – –
Ameriprise
40
Ameriprise
Minnesota
$1.18M +$779K +40,620 +152%
AA
41
ALPS Advisors
Colorado
$1.18M +$360K +18,801 +39%
Squarepoint
42
Squarepoint
New York
$1.12M +$566K +29,520 +86%
Walleye Capital
43
Walleye Capital
New York
$1.05M +$1.15M +59,932 New
Morgan Stanley
44
Morgan Stanley
New York
$963K -$483K -25,197 -31%
TA
45
Teachers Advisors
New York
$893K +$164K +8,536 +20%
Citigroup
46
Citigroup
New York
$853K +$369K +19,229 +65%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$817K +$379K +19,748 +73%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$753K +$96.1K +5,015 +13%
Swiss National Bank
49
Swiss National Bank
Switzerland
$739K – – –
Wells Fargo
50
Wells Fargo
California
$739K +$259K +13,489 +47%
1
2
3 4 5

KURA Hedge Fund Activity: Q3 2018 in Review

116 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2018, worth a combined $529M — down 2.1% from $541M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 54 added to existing stakes and 27 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $13.5M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 116 institutional investors held Kura Oncology (KURA) as of Q3 2018, up from 107 in Q2 2018.
  • Funds reported $529M of Kura Oncology stock for Q3 2018, down 2.1% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q3 2018 and 10 closed out, a net change of +9 holders.
  • The largest Kura Oncology buyer in Q3 2018 was Eagle Asset Management, an estimated $13.5M added.
  • The largest Kura Oncology seller in Q3 2018 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q3 2018.